Research Site 652 is a clinical research site located in Tallahassee, Florida, United States 32308.
Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.
Research Site 652 has participated in 1 clinical trials.
Therapeutic areas: Relapsing Multiple Sclerosis.
Sponsors: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Florida · View every site in Tallahassee
Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Research Site 652 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Research Site 652 has 1 clinical trials on record. Their work covers Relapsing Multiple Sclerosis.
Research Site 652 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.